Selected research
Market Structure
Global Veterinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Veterinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Veterinary Drugs include Zoetis Inc., Merck Animal Health, Bayer AG, Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Elanco, Covetrus, Inc. and Ceva Sante Animale S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Veterinary Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Veterinary Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Veterinary Drugs Segment by Company
Zoetis Inc.
Merck Animal Health
Bayer AG
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Elanco
Covetrus, Inc.
Ceva Sante Animale S.A.
Boehringer Ingelheim Animal Health
Veterinary Drugs Segment by Type
Treatment Drugs
Vaccines
Others
Veterinary Drugs Segment by Application
Chickens
Cattle
Swine
Others
Veterinary Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Veterinary Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Drugs industry.
Chapter 3: Detailed analysis of Veterinary Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Treatment Drugs
- Vaccines
- Others
Applications
- Chickens
- Cattle
- Swine
- Others
Companies covered
- Zoetis Inc.
- Merck Animal Health
- Bayer AG
- Virbac SA
- Vetoquinol SA
- IDEXX Laboratories, Inc.
- Elanco
- Covetrus, Inc.
- Ceva Sante Animale S.A.
- Boehringer Ingelheim Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Veterinary Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Treatment Drugs
- 1.2.3 Vaccines
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Veterinary Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Chickens
- 1.3.3 Cattle
- 1.3.4 Swine
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Veterinary Drugs Growth Trends by Region
- 1.5.1 Global Veterinary Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Veterinary Drugs Market Size by Region (2021-2026)
- 1.5.3 Veterinary Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Veterinary Drugs Market Dynamics
- 2.1 Veterinary Drugs Industry Trends
- 2.2 Veterinary Drugs Industry Drivers
- 2.3 Veterinary Drugs Industry Opportunities and Challenges
- 2.4 Veterinary Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Veterinary Drugs Revenue by Company (2021-2026)
- 3.2 Global Veterinary Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Veterinary Drugs Key Company Head office and Area Served
- 3.4 Global Veterinary Drugs Company, Product Type & Application
- 3.5 Global Veterinary Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Veterinary Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Veterinary Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Veterinary Drugs Tier 1, Tier 2, and Tier 3
4 Veterinary Drugs Market by Type
- 4.1 Global Veterinary Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Veterinary Drugs Market Size by Type (2021-2032)
- 4.3 Global Veterinary Drugs Market Size Share by Type (2021-2032)
5 Veterinary Drugs Market by Application
- 5.1 Global Veterinary Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary Drugs Market Size by Application (2021-2032)
- 5.3 Global Veterinary Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Zoetis Inc.
- 6.1.1 Zoetis Inc. Company Information
- 6.1.2 Zoetis Inc. Business Overview
- 6.1.3 Zoetis Inc. Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Zoetis Inc. Veterinary Drugs Product Portfolio
- 6.1.5 Zoetis Inc. Recent Developments
- 6.2 Merck Animal Health
- 6.2.1 Merck Animal Health Company Information
- 6.2.2 Merck Animal Health Business Overview
- 6.2.3 Merck Animal Health Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck Animal Health Veterinary Drugs Product Portfolio
- 6.2.5 Merck Animal Health Recent Developments
- 6.3 Bayer AG
- 6.3.1 Bayer AG Company Information
- 6.3.2 Bayer AG Business Overview
- 6.3.3 Bayer AG Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bayer AG Veterinary Drugs Product Portfolio
- 6.3.5 Bayer AG Recent Developments
- 6.4 Virbac SA
- 6.4.1 Virbac SA Company Information
- 6.4.2 Virbac SA Business Overview
- 6.4.3 Virbac SA Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Virbac SA Veterinary Drugs Product Portfolio
- 6.4.5 Virbac SA Recent Developments
- 6.5 Vetoquinol SA
- 6.5.1 Vetoquinol SA Company Information
- 6.5.2 Vetoquinol SA Business Overview
- 6.5.3 Vetoquinol SA Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Vetoquinol SA Veterinary Drugs Product Portfolio
- 6.5.5 Vetoquinol SA Recent Developments
- 6.6 IDEXX Laboratories, Inc.
- 6.6.1 IDEXX Laboratories, Inc. Company Information
- 6.6.2 IDEXX Laboratories, Inc. Business Overview
- 6.6.3 IDEXX Laboratories, Inc. Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 IDEXX Laboratories, Inc. Veterinary Drugs Product Portfolio
- 6.6.5 IDEXX Laboratories, Inc. Recent Developments
- 6.7 Elanco
- 6.7.1 Elanco Company Information
- 6.7.2 Elanco Business Overview
- 6.7.3 Elanco Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Elanco Veterinary Drugs Product Portfolio
- 6.7.5 Elanco Recent Developments
- 6.8 Covetrus, Inc.
- 6.8.1 Covetrus, Inc. Company Information
- 6.8.2 Covetrus, Inc. Business Overview
- 6.8.3 Covetrus, Inc. Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Covetrus, Inc. Veterinary Drugs Product Portfolio
- 6.8.5 Covetrus, Inc. Recent Developments
- 6.9 Ceva Sante Animale S.A.
- 6.9.1 Ceva Sante Animale S.A. Company Information
- 6.9.2 Ceva Sante Animale S.A. Business Overview
- 6.9.3 Ceva Sante Animale S.A. Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Ceva Sante Animale S.A. Veterinary Drugs Product Portfolio
- 6.9.5 Ceva Sante Animale S.A. Recent Developments
- 6.10 Boehringer Ingelheim Animal Health
- 6.10.1 Boehringer Ingelheim Animal Health Company Information
- 6.10.2 Boehringer Ingelheim Animal Health Business Overview
- 6.10.3 Boehringer Ingelheim Animal Health Veterinary Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Boehringer Ingelheim Animal Health Veterinary Drugs Product Portfolio
- 6.10.5 Boehringer Ingelheim Animal Health Recent Developments
7 North America
- 7.1 North America Veterinary Drugs Market Size (2021-2032)
- 7.2 North America Veterinary Drugs Market Size by Type
- 7.2.1 North America Veterinary Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Veterinary Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Veterinary Drugs Market Share by Type (2021-2032)
- 7.3 North America Veterinary Drugs Market Size by Application
- 7.3.1 North America Veterinary Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Veterinary Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Veterinary Drugs Market Share by Application (2021-2032)
- 7.4 North America Veterinary Drugs Market Size by Country
- 7.4.1 North America Veterinary Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Veterinary Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Veterinary Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Veterinary Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Veterinary Drugs Market Size (2021-2032)
- 8.2 Europe Veterinary Drugs Market Size by Type
- 8.2.1 Europe Veterinary Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Veterinary Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Veterinary Drugs Market Share by Type (2021-2032)
- 8.3 Europe Veterinary Drugs Market Size by Application
- 8.3.1 Europe Veterinary Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Veterinary Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Veterinary Drugs Market Share by Application (2021-2032)
- 8.4 Europe Veterinary Drugs Market Size by Country
- 8.4.1 Europe Veterinary Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Veterinary Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Veterinary Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Veterinary Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Veterinary Drugs Market Size (2021-2032)
- 9.2 China Veterinary Drugs Market Size by Type
- 9.2.1 China Veterinary Drugs Market Size by Type (2021-2026)
- 9.2.2 China Veterinary Drugs Market Size by Type (2027-2032)
- 9.2.3 China Veterinary Drugs Market Share by Type (2021-2032)
- 9.3 China Veterinary Drugs Market Size by Application
- 9.3.1 China Veterinary Drugs Market Size by Application (2021-2026)
- 9.3.2 China Veterinary Drugs Market Size by Application (2027-2032)
- 9.3.3 China Veterinary Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Veterinary Drugs Market Size (2021-2032)
- 10.2 Asia Veterinary Drugs Market Size by Type
- 10.2.1 Asia Veterinary Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Veterinary Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Veterinary Drugs Market Share by Type (2021-2032)
- 10.3 Asia Veterinary Drugs Market Size by Application
- 10.3.1 Asia Veterinary Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Veterinary Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Veterinary Drugs Market Share by Application (2021-2032)
- 10.4 Asia Veterinary Drugs Market Size by Country
- 10.4.1 Asia Veterinary Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Veterinary Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Veterinary Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Veterinary Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Veterinary Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Veterinary Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Veterinary Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Veterinary Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Veterinary Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Veterinary Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Veterinary Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Veterinary Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Veterinary Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Veterinary Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Veterinary Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Veterinary Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Veterinary Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Veterinary Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst